NeoSCB App for Screening Jaundice in Newborns

Launched by UNIVERSITY COLLEGE, LONDON · May 6, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new smartphone app called "neoSCB," which helps detect jaundice in newborn babies. Jaundice is a common condition in newborns, where their skin and eyes turn yellow due to high levels of a substance called bilirubin in their blood. While healthcare providers usually check for jaundice by looking at the baby, this method isn't always accurate and can lead to unnecessary blood tests. The neoSCB app aims to improve this process by taking a photo of the baby’s eye and using a special program to quickly and accurately determine if jaundice is serious enough to require treatment.

To participate in this trial, babies need to be between 0 and 28 days old, and they can have jaundice or not. However, babies who are very sick and need immediate medical care, or those who have recently received treatment for jaundice, cannot join. If a baby is eligible, their family can expect to use the app to help assess jaundice levels, and the trial will also explore whether the app is cost-effective compared to other existing devices. Researchers will gather feedback from families and doctors to make the app even better.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Term newborn babies with and without jaundice (postnatal age 0 day to 28 days)
• Exclusion Criteria:
• • Newborn babies who are clinically unwell and require urgent medical attention, and babies who have received phototherapy recently